Literature DB >> 10081864

Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old.

T Rhodes1, C J Girman, S J Jacobsen, R O Roberts, H A Guess, M M Lieber.   

Abstract

PURPOSE: We estimate the rate of prostate growth in randomly selected healthy community dwelling men.
MATERIALS AND METHODS: Prostate volume in an age stratified random sample of 631 white male residents of Olmsted County, Minnesota 40 to 79 years old without prior prostate surgery or prostate cancer was measured up to 4 times by transrectal ultrasound during a followup period of almost 7 years.
RESULTS: Estimated prostate growth rates increased with increasing age. However, the estimated average annual change was 1.6% across all age groups. Estimated prostate growth rates were high depending on baseline prostate volume with higher growth rates for men with larger prostates.
CONCLUSIONS: While there is wide variability in prostate growth rates on an individual level, prostate volume appears to increase steadily at about 1.6% per year in randomly selected community men.

Entities:  

Mesh:

Year:  1999        PMID: 10081864

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  48 in total

Review 1.  The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data.

Authors:  Jaspreet S Sandhu; Alexis E Te
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

Review 2.  The use of baseline clinical measures to predict those at risk for progression of benign prostatic hyperplasia.

Authors:  Edward D Kim
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

Review 3.  Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options.

Authors:  Jaspreet S Sandhu; E Darracott Vaughan
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Relationship between age and prostate size.

Authors:  Shi-Jun Zhang; Hai-Ning Qian; Yan Zhao; Kai Sun; Hui-Qing Wang; Guo-Qing Liang; Feng-Hua Li; Zheng Li
Journal:  Asian J Androl       Date:  2012-12-10       Impact factor: 3.285

Review 5.  Prostate stem cells and benign prostatic hyperplasia.

Authors:  John T Isaacs
Journal:  Prostate       Date:  2008-06-15       Impact factor: 4.104

Review 6.  Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.

Authors:  Andrea Tubaro; Simon Carter; Alberto Trucchi; Giorgio Punzo; Stefano Petta; Lucio Miano
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Intravesical prostatic protrusion in men in Olmsted County, Minnesota.

Authors:  Michael M Lieber; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Cynthia J Girman; Steven J Jacobsen
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

8.  Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.

Authors:  Jae-Seung Paick; Soo Woong Kim; Ja Hyeon Ku
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

9.  Therapeutic options in the treatment of benign prostatic hyperplasia.

Authors:  Jaspreet S Sandhu
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

10.  False-positive screening results in the Finnish prostate cancer screening trial.

Authors:  T P Kilpeläinen; T L J Tammela; L Määttänen; P Kujala; U-H Stenman; M Ala-Opas; T J Murtola; A Auvinen
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.